Walter and Eliza Hall Institute scientists have identified a key step in the biological process of programmed cell death, also called apoptosis.
Apoptosis is important in human biology as it removes unwanted and sometimes dangerous cells from our bodies, protecting us against cancer development. It can also, however, lead to the development of degenerative diseases when healthy cells are errantly destroyed.
The research, led by Dr Ruth Kluck from the institute's Molecular Genetics of Cancer Division, is crucial to the development of drugs that can turn on apoptosis, thereby more effectively killing cancer cells. It could also be used in developing compounds that turn off the apoptosis that leads to degenerative disorders.
Dr Kluck has been investigating the role in apoptosis of two proteins, Bak and Bax. It is thought that understanding their role will identify targets against which drugs to regulate cell death could be designed.
"The pivotal step towards cell death is the formation of a pore in the mitochondria; mitochondria make and supply energy to the cells," Dr Kluck said. "Pore formation is the point of no return in apoptotic cell death as it allows cytochrome c, which is the protein that initiates cell death, to escape from the mitochondria. Only two proteins are known to form the pore, Bak and Bax."
In 2008 Dr Kluck and her colleagues published their finding that, in order to form the pore, Bak first changes shape and then combines with another Bak protein to form a doublet.
"We have now identified the second step in how Bak forms that pore," Dr Kluck said. "Once the doublet is formed it can combine with other Bak doublets by what's called a second interface. This second interface seems to allow doublets to assemble into the larger complexes that form the pore."
The team of Dr Kluck, Dr Grant Dewson, Mr Tobias Kratina, Dr Peter Czabotar and Professor Jerry Adams from the institute and Dr
|Contact: Penny Fannin|
Walter and Eliza Hall Institute